Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Cultured dermal papilla cells can regenerate hair follicles and sustain hair growth.

EGF controls hair growth by regulating hair follicles' growth phases.

HS patients rarely see dermatologists, often get opiates, and need better care.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Dupilumab for eczema may cause hair loss.

Immune cells affect hair growth and could lead to new hair loss treatments.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Denosumab treatment for osteoporosis can cause hair loss.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

TNF-alpha inhibitors can cause various immune-related skin issues.

The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Psoriasis is a common, genetically influenced skin disease worsened by stress and lifestyle, but targeted treatments are promising.